Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
Podcast will Extend Reach of Oncotarget to Professional Scientists and the Public
ORCHARD PARK, N.Y., Nov. 8, 2017 /PRNewswire/ -- Oncotarget, the world's largest oncology peer-reviewed research publication, is set to extend its reach with a series of podcasts that will allow scientists to delve deeper into a variety of research contributions found in the journal.
Subscribers to the new podcast series will gain access to the journal's most important discoveries through full readings of published papers, interviews with outstanding authors, and selected readings from the Oncotarget blog. The podcast will highlight topics in oncology and beyond, including aging, pathology, immunology and microbiology, autophagy, chromosome, neuroscience, endocrinology, cardiology, metabolism, cell biology, pharmacology and more on Stitcher, Blubrry, and Soundcloud.
"Our mission has always been to make exceptional discoveries rapidly and widely available, eliminate borders between specialties by linking different fields of biomedical science and foster applications of basic and clinical science," said Mikhail Blagosklonny, Oncotarget's editor-in-chief. "This new podcast series will be another way to deliver people free access to the research published in this journal."
The podcast series will contain multiple streams that will target a variety of listeners.
In addition to providing an additional free service to its readers, the podcast benefits the publication's authors as they seek to communicate their findings and disseminate their research to pertinent stakeholders.
"Oncotarget does not stop once the paper is published," said Blagosklonny. "It is only halfway done. This podcast is part of an enhanced post publication service Oncotarget provides to authors of its papers by helping them to reach a wider audience." This service includes publicizing the research on Oncotarget's homepage, its social platforms, and via its other public relations efforts.
Oncotarget is twice-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology and publishing sub-sections on topics beyond oncology such as Aging, Immunology and Microbiology, Autophagy, Pathology and Chromosomes and more. Oncotarget is published by Rapamycin Press, the publishing division of Impact Journals LLC.
Media Contact Information:
Ryan James Jessup
+1 202 638 9720
©2017 PR Newswire. All Rights Reserved.